For insemination to be successful, it must be performed before ovulation. To detect ovulation, urine ovulation predictor kits (OPK) are recommended, which detect the surge in luteinizing hormone (LH), which is one of the primary hormones responsible for ovulation. These kits are available at PCRM, as well as most pharmacies without a prescription. Electronic fertility computers or monitors are not recommended while using fertility medication as the higher hormone levels may give a false reading.
IUI is typically performed alongside superovulation, also known as Controlled Ovarian Hyperstimulation (COH), which involves using medications to stimulate the ovaries into producing more eggs within a single cycle. Combined with IUI, this technique has been demonstrated to be an effective method of treatment for patients where less invasive therapies have not been successful in achieving a pregnancy.
The goal of superovulation is to increase the number of eggs released (3-4 per cycle) during ovulation to help offset the normal age-related decline in egg quality. Multiple eggs are generated with the administration of follicle-stimulating hormone (FSH), which is the same hormone that the female brain naturally produces to make eggs. Given the potential for the production of an excessive number of eggs, patients undergoing IUI require close supervision through a fertility centre to monitor ovarian follicle numbers and estradiol levels.
Once the follicles have reached the optimum size (18-20 mm), an injection of a hormone called human chorionic gonadotrophin hCG is given to “trigger” ovulation. HCG is sometimes referred to as “the pregnancy hormone” because it’s produced by the placenta during pregnancy. It’s also structurally very similar to the LH hormone that naturally causes ovulation. Intrauterine inseminations are typically performed 24 to 36 hours after the trigger shot has been administered. Superovulation is generally always recommended with IUI, as it has been shown to optimize the likelihood of conception.
The most common side effects of superovulation are lower abdominal fullness and bloating. The most significant risks are high-order multiple pregnancies and ovarian hyperstimulation syndrome (OHSS). The majority of multiple pregnancies are twins, however, more than two fetuses can sometimes develop. The risk of high-order multiples is actually greater with superovulation cycles compared to IVF since the number of eggs ovulated cannot be precisely controlled in IUI, unlike IVF where eggs are retrieved and a select number of embryos are created and transferred to the uterus. Typically with ovulation pills, these risks are minimal, all patients will require is ovulation kit testing.